Next Article in Journal
Application of Ionic Liquids in Hydrometallurgy
Previous Article in Journal
Dual Targeting Biomimetic Liposomes for Paclitaxel/DNA Combination Cancer Treatment
Article Menu
Issue 9 (September) cover image

Export Article

Open AccessArticle
Int. J. Mol. Sci. 2014, 15(9), 15304-15319; doi:10.3390/ijms150915304

T Lymphocyte Antigen 4-Modified Dendritic Cell Therapy for Asthmatic Mice Guided by the CCR7 Chemokine Receptor

1,3
,
2
and
3,4,*
1
Department of Respiratory Medicine, Children's Hospital of Fudan University, Shanghai 201102, China
2
Department of Neonatology, Children's Hospital, Chongqing Medical University, Chongqing 404100, China
3
Department of Respiratory Medicine, Children's Hospital, Chongqing Medical University, Chongqing 404100, China
4
Respiratory Research Laboratory, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing 404100, China
*
Author to whom correspondence should be addressed.
Received: 2 June 2014 / Revised: 30 June 2014 / Accepted: 12 August 2014 / Published: 29 August 2014
(This article belongs to the Section Biomaterial Sciences)
View Full-Text   |   Download PDF [1770 KB, uploaded 29 August 2014]   |  

Abstract

The CD80/CD86-CD28 axis is a critical pathway for immuno-corrective therapy, and the cytotoxic T lymphocyte antigen 4 (CTLA4) is a promising immunosuppressor targeting the CD80/CD86-CD28 axis; however, its use for asthma therapy needs further optimization. A human CTLA4 fused with the IgCγ Fc (CTLA4Ig) and mouse CC chemokine receptor type7 (CCR7) coding sequences were inserted into a recombinant adenovirus (rAdV) vector to generate rAdV-CTLA4Ig and rAdV-CCR7. The naive dendritic cells (DCs) were infected with these rAdVs to ensure CCR7 and CTLA4Ig expression. The therapeutic effects of modified DCs were evaluated. rAdV-CTLA4Ig and rAdV-CCR7 infected DCs improved all asthma symptoms. Inflammatory cell infiltration and cytokine analysis showed that rAdV-CTLA4Ig and rAdV-CCR7-modified DC therapy reduced the number of eosinophils and lymphocyte and neutrophil infiltration in the lung. Interestingly, assessment of the humoral immunity showed that the IL-4 and IFNγ levels of the rAdV-CTLA4Ig and rAdV-CCR7-modified DC-treated mice decreased significantly and did not reverse the Th1/Th2 balance. DCs expressing CCR7 displayed guidance ability for DC migration, primarily for DCs in the inflammatory lung. Additionally, the rAdVs caused an inflammatory response by inducing DC differentiation, inflammatory cell infiltration and changes in cytokines; however, mice transplanted with rAdV-green fluorescent protein (GFP)-infected DCs displayed no asthma manifestations. In conclusion, CTLA4Ig-modified DCs exhibited a therapeutic effect on asthma, and CCR7 may guide DC homing. The combination of these two molecules may be a model for precision-guided immunotherapy. View Full-Text
Keywords: the cytotoxic T lymphocyte antigen 4 (CTLA4); asthma; chemokine receptor CCR7; dendritic cells (DCs); recombinant viral vectors; precision-guided immunotherapy the cytotoxic T lymphocyte antigen 4 (CTLA4); asthma; chemokine receptor CCR7; dendritic cells (DCs); recombinant viral vectors; precision-guided immunotherapy
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Chen, Y.; Wang, Y.; Fu, Z. T Lymphocyte Antigen 4-Modified Dendritic Cell Therapy for Asthmatic Mice Guided by the CCR7 Chemokine Receptor. Int. J. Mol. Sci. 2014, 15, 15304-15319.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top